Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-18

FDA Approved: OXAPROZIN — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for Oxaprozin from Dr. Reddy's Laboratories Limited, indicating an approved change to the previously approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxaprozin (Oxaprozin)

Snippet

SUPPL AP for OXAPROZIN (OXAPROZIN)